MARCO MANDALARI

Dr. MARCO MANDALARI

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
MMMARCO MANDALARI
MARCO MANDALARI
MPMichela Parafioriti
Michela Parafioriti
MNMinghong Ni
Minghong Ni
FBFrancesca Benevelli
Francesca Benevelli
MCMonica Civera
Monica Civera
MGMarco Guerrini
Marco Guerrini
Heparan sulfate proteoglycans serve as initial attachment sites for several viruses and bacteria. Recent studies suggest that SARS-CoV-2 similarly exploits these glycosaminoglycans, facilitating conformational changes in the spike protein that promote the interaction between the receptor-binding domain (S1-RBD) and the cellular angiotensin-converting enzyme 2 receptor (ACE2), thereby triggering the virus internalization process. The molecular details that drive this process, particularly the co-receptor role of heparan sulfate (HS), remain incompletely understood. The interaction between an HS hexasaccharide (hexa) and the N343 glycosylated S1-RBD of the wild-type (WT) and Omicron variant of SARS-CoV-2 was investigated. The conformational properties of hexa with these S1-RBDs in unbound and bound states are explored using multiple independent MD simulations; the protein binding epitope of hexa, as well as the details of its interaction with S1-RBD of the Omicron variant, are characterized by comparing experimental and theoretical 1H STD NMR signals. This investigation identifies the role played by the glycosyl moiety at N343 in potentially affecting this interaction in both WT and Omicron S1-RBD, explaining the observed low specificity and multi-modal nature of the interaction between HS oligosaccharides and these S1-RBDs.

26 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMARCO MANDALARI
MARCO MANDALARI
MPMichela Parafioriti
Michela Parafioriti
MNMinghong Ni
Minghong Ni
FBFrancesca Benevelli
Francesca Benevelli
MCMonica Civera
Monica Civera
MGMarco Guerrini
Marco Guerrini
Heparan sulfate proteoglycans are known to serve as initial attachment site for several viruses and bacteria. Recent studies suggest that SARS-CoV-2 coronavirus similarly exploits these glycosaminoglycans, facilitating conformational changes in the spike protein, that promotes the interaction between the receptor binding domain (S1-RBD) and the cellular angiotensin-converting enzyme 2 receptor (ACE2), thereby triggering the virus internalization process. Until now, the molecular details that drive this process, particularly, the co-receptor role of the heparan sulfate (HS), remain not completely understood. Our research seeks to characterize the interaction between an HS hexasaccharide (hexa) and the N343 glycosylated S1-RBD of the Omicron and wild-type (WT) variants of SARS-CoV-2. The conformational properties of hexa in unbound and bound state with these S1-RBDs are investigated using multiple independent MD simulations; the proton binding epitope of hexa, as well as the details of the interaction between this glycan and S1-RBD of the Omicron variant, are characterized by comparing experimental and theoretical saturation transfer difference NMR signals. This investigation reinforces previous evidence about the low specificity and multi-modal nature of the interaction between HS oligosaccharides and these S1-RBDs, and underlines the role of the glycosyl moiety at N343 in potentially affecting this interaction in both selected variants.